|
|
|
|
|
|
Rexahn Pharmaceuticals (RNN)
|
|
3.15 +0.14 (+4.65%)
|
6/23/2017 4:02pm
|
|
Open:
|
3.02
|
Pre. Close:
|
3.01
|
|
High:
|
3.17
|
Low:
|
2.99
|
|
Volume:
|
236,523
|
Market Cap:
|
80.08M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
3.24 - 3.33
|
3.33 - 3.61
|
|
Low:
|
2.79 - 2.85
|
2.85 - 3.03
|
|
Close:
|
3.04 - 3.15
|
3.15 - 3.49
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-23 4:38:00 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 4.47 One year: 5.10
|
|
Support:
|
Support1: 2.95 Support2: 2.45
|
|
Resistance:
|
Resistance1:
3.83 Resistance2: 4.37
|
|
Pivot:
|
3.36 
|
|
Moving Averages:
|
MA(5): 3.03  MA(20): 3.50
MA(100): 3.72 MA(250): 2.73
|
|
MACD:
|
MACD(12,26):
-0.28 Signal(12,26,9): -0.26
|
|
%K %D:
|
%K(14,3): 6.84 %D(3): 4.33
|
|
RSI:
|
RSI(14): 38.61
|
|
52-Week:
|
High: 7.10
Low: 0.38 Change(%): 18.4
|
|
Average Vol(K):
|
3-Month: 606
10-Days 220
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.RNN has closed above bottom band by 37.7%. Bollinger Bands are 10.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Mon, 17 Apr 2017 15:33:45 GMT
Could Rexahn Pharmaceuticals Have Something?
Mon, 08 May 2017 13:02:52 GMT
Rexahn Pharmaceuticals to Present RX-3117 Clinical Data at the American ...
Sun, 04 Jun 2017 12:56:15 GMT
Rexahn Pharmaceuticals Presents Preliminary Efficacy Data from the Ongoing ...
Tue, 03 Jan 2017 14:00:20 GMT
Rexahn Pharmaceuticals to Present at Biotech Showcase™ 2017
Thu, 13 Apr 2017 13:01:03 GMT
Rexahn Announces 1-for-10 Reverse Stock Split
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
